Another study in RA patients revealed a decrease in peripheral CD45RA-FoxP3high activated Treg cells (Fr II) compared to HC [30], but that study assessed Fr II in (longstanding) RA-patients who were mainly treated with DMARDs and anti-TNF-α and not treatment-naive RA patients as assessed in our study. Here, TNF is linked to rheumatoid arthritis.